These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6917562)

  • 21. Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system.
    Müller-Esterl W; Hock H; Rauth G; Kellermann J; Lottspeich F; Henschen A
    Adv Exp Med Biol; 1986; 198 Pt A():97-103. PubMed ID: 3643720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of arginine residues in the coagulant activity of high molecular weight kininogen.
    Chang JJ; Scott CF; Colman RW
    Blood; 1986 Mar; 67(3):805-10. PubMed ID: 3633200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of bovine factor XII (Hageman factor) by plasma kallikrein.
    Fujikawa K; Heimark RL; Kurachi K; Davie EW
    Biochemistry; 1980 Apr; 19(7):1322-30. PubMed ID: 6155941
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine Factor XII.
    Kato H; Sugo T; Ikari N; Hashimoto N; Maruyama I; Han YN; Iwanaga S; Fujii S
    Adv Exp Med Biol; 1979; 120B():19-37. PubMed ID: 390983
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of surface-mediated activation of bovine factor XII and plasma prekallikrein.
    Sugo T; Hamaguchi A; Shimada T; Kato H; Iwanaga S
    J Biochem; 1982 Sep; 92(3):689-98. PubMed ID: 6923896
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
    Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
    J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
    Walsh PN; Griffin JH
    Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
    [No Abstract]   [Full Text] [Related]  

  • 37. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human high molecular weight kininogen as a thiol proteinase inhibitor: presence of the entire inhibition capacity in the native form of heavy chain.
    Higashiyama S; Ohkubo I; Ishiguro H; Kunimatsu M; Sawaki K; Sasaki M
    Biochemistry; 1986 Apr; 25(7):1669-75. PubMed ID: 3635411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of activation of bovine factor XI by factor XII and factor XIIa.
    Kurachi K; Fujikawa K; Davie EW
    Biochemistry; 1980 Apr; 19(7):1330-8. PubMed ID: 6155942
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.
    Chan JY; Habal FM; Burrowes CE; Movat HZ
    Thromb Res; 1976 Nov; 9(5):423-33. PubMed ID: 996830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.